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Carys Jones*, Rhiannon Tudor Edwards and Barry HounsomeAbstract
Advisory bodies, such as the National Institute for Health and Clinical Excellence (NICE) in the UK, advocate using
preference based instruments to measure the quality of life (QoL) component of the quality-adjusted life year
(QALY). Cost per QALY is used to determine cost-effectiveness, and hence funding, of interventions. QALYs allow
policy makers to compare the effects of different interventions across different patient groups. Generic measures
may not be sensitive enough to fully capture the QoL effects for certain populations, such as carers, so there is a
need to consider additional outcome measures, which are preference based where possible to enable
cost-effectiveness analysis to be undertaken. This paper reviews outcome measures commonly used in health
services research and health economics research involving carers of people with dementia. An electronic database
search was conducted in PubMed, Medline, the Cumulative Index to Nursing and Allied Health Literature (CINAHL),
PsycINFO, the National Health Service Economic Evaluation Database (NHS EED), Database of Abstracts of Reviews
of Effects (DARE) and Health Technology Assessment database. Studies were eligible for inclusion if they included
an outcome measure for carers of people with dementia. 2262 articles were identified. 455 articles describing 361
studies remained after exclusion criteria were applied. 228 outcome measures were extracted from the studies.
Measures were categorised into 44 burden measures, 43 mastery measures, 61 mood measures, 32 QoL measures,
27 social support and relationships measures and 21 staff competency and morale measures. The choice of
instrument has implications on funding decisions; therefore, researchers need to choose appropriate instruments for
the population being measured and the type of intervention undertaken. If an instrument is not sensitive enough
to detect changes in certain populations, the effect of an intervention may be underestimated, and hence
interventions which may appear to be beneficial to participants are not deemed cost-effective and are not funded.
If this is the case, it is essential that additional outcome measures which detect changes in broader QoL are
included, whilst still retaining preference based utility measures such as EQ-5D to allow QALY calculation for
comparability with other interventions.
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In the UK, the government faces an increasing challenge
to meet the growing demands on the healthcare system.
Despite increased public expectations of treatment avail-
ability, an ageing population and higher levels of chronic
disease, the government is aiming to achieve efficiency
savings of £20 billion in the National Health Service’s* Correspondence: c.l.jones@bangor.ac.uk
Centre for Health Economics and Medicines Evaluation, IMSCaR, College of
Health and Behavioural Sciences, Bangor University, Dean Street Building,
Gwynedd LL57 1UT, UK
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reproduction in any medium, provided the or(NHS) budget by 2014 [1]. Savings are to be made
through focusing on quality, innovation, productivity
and prevention. Treatments offered on the NHS must be
clinically effective and cost-effective, as assessed by the
National Institute for Health and Clinical Excellence
(NICE). The NICE guide to technology appraisal [2]
states that cost-effectiveness should be reported in Qual-
ity Adjusted Life Years (QALYs), a measure combining
length of time with quality of life (QoL). Therefore, the
choice of instrument used to measure QoL is important,
as the resulting QALY calculations determine whether atd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Articles identified through 
database searches: n= 2262 
Articles excluded: n=1638
No carer outcome measure: n= 764
Not dementia carers: n= 352 
Commentary/ guidelines: n= 267 
Systematic review articles: n= 255 
Screening based on title and 
abstract 
Articles retrieved for review: n= 
455 (361 unique studies + 94 
articles reporting results from 
studies already included) 
Articles remaining: n= 2093 
Duplicates excluded: n= 169 
Figure 1 Flow of articles retrieved through electronic searches.
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The issue of NICE cost-effectiveness funding thresholds
may only be applicable to the UK; however, the meth-
odological issue of measuring and valuing carer benefits
has international application.
Dementia places a large burden on the economy, with
costs incurred by the health care sector, social care sec-
tor and informal carers [3]. The largest proportion of
the cost (55%) is incurred by informal carers looking
after a friend or relative, and is indicative of the burden
faced by carers. Carer burden can predict institutionali-
sation of the person with dementia [4,5]; therefore evi-
dence of effective methods to support carers in their
role needs to be established to delay institutionalisation
and the associated costs. Burden can affect QoL through
decreased mental wellbeing caused by stress and worry,
and also the opportunity cost of reduced time for leisure
activities and self-care [6].
The need to use appropriate outcome measures in
health economics research has been recognised [7-9].
Interventions involving people with dementia and their
carers may be complex with multiple objectives; there-
fore it is necessary to consider multiple outcome mea-
sures. Focusing on one attribute, such as QoL, may lead
to other benefits being overlooked. Moniz-Cook et al.
[10] argued that a more cohesive approach to outcome
measurement in dementia care research will lead to a
more robust evidence base. Health economists require
preference based utility measures for calculating QALYs.
However, restricting benefit measurement to health-
related outcomes in carer research places a patient iden-
tity on the carer, which may not be appropriate [11].
This article aims to address the question ‘what outcome
measures are used most frequently in interventions in-
volving carers of people with dementia, and how useful
are these measures for economic evaluation?’
Methods
A systematic literature search of electronic databases
was conducted on 1st March, 2012. PRISMA reporting
principles were used as guidance [12]. PubMed (1946–
2012), Medline (1950–2012), the Cumulative Index to
Nursing and Allied Health Literature (CINAHL) (1981–
2012), PsycINFO (1806–2012), and the NHS Centre for
Reviews and Dissemination (containing the National
Health Service Economic Evaluation Database (NHS
EED), Database of Abstracts of Reviews of Effects
(DARE) and Health Technology Assessment database)
(1960–2012) were searched. Titles, keywords and
abstracts were searched for the terms caregiver, rando-
mized controlled trials and dementia or Alzheimer’s dis-
ease using MeSH terms where possible. The search
strategy for each database is presented in Additional file
1: Appendix 1. No restriction on publication year wasset. Study eligibility was based on initial screening of title
and abstract. Articles passing initial screening were
retrieved for further review.
Studies were considered if they reported an interven-
tion with outcome measures for carers of people with
dementia. Carers could be paid workers or informal
carers, such as friends and family members. We included
outcomes for paid carers to get a broader indication of
which aspects of health and social care provision are
typically measured. No gender, age or nationality restric-
tions were applied. The person being cared for could be
living in residential care, a medical facility or the
community.
Carer outcome measures were extracted and cate-
gorised. The categories used in Moniz-Cook et al. [10]
were a starting point: burden, mood, quality of life and
staff competency and morale. Two additional categories
were developed after reviewing the data: mastery and so-
cial support and relationships.
Results
2262 records were retrieved, 2093 articles remained after
duplicates were removed (Figure 1). After screening
titles and abstracts, 1638 articles were excluded. Exclu-
sion reasons included no carer outcome measure (764
articles), the population not consisting of dementia
carers (352 articles), commentary articles or clinical
practice guidelines (267 articles) and systematic review
articles (255 articles). 455 articles reporting on 361 stud-
ies remained. 228 outcome measures were extracted. A
full list of extracted outcome measures, the number of
studies they appeared in and their earliest and most re-
cent year is in Additional file 2: Appendix 2. Table 1 pre-
sents key properties of outcome measures appearing in
Table 1 Properties of the most frequently used outcome measures












Burden Zarit Burden Interview 76 (21.1%) 1983 USA 22 5 Yes
Revised Memory and Behavior
Problems Checklist (RMBPC)
44 (12.2%) 1992 USA 24 6 Yes
Relatives Stress Scale 13 (3.6%) 1982 UK 15 5 Yes
Novak Caregiver Burden Inventory 11 (3.0%) 1989 Canada 24 4 Yes
Screen for Caregiver burden 11 (3.0%) 1991 USA 25 5 Yes
Perceived Stress Scale 11 (3.0%) 1983 USA 14 5 No
(Revised) Caregiving Burden Scale 6 (1.7%) 1994 Netherlands 13 5 Yes
Caregiver Stress Scale 4 (1.1%) 1990 USA 15 3-5 Yes
Mastery Sense of Competence Questionnaire 12 (3.3%) 1996 Netherlands 27 2-5 Yes
Brief Coping Orientation for Problems
Experienced (COPE)
6 (1.7%) 1997 USA 28 4 No
Ways of coping scale 6 (1.7%) 1985 USA 64 2 No
Revised Scale for Caregiving Self
Efficacy
6 (1.7%) 1999 USA 19 Rated 0-100 No
Mood Center for Epidemiologic Studies
Depression Scale (CES-D)
57 (15.8%) 1977 USA 20 4 No
General Health Questionnaire (GHQ)1 31 (8.6%) 1978 UK 28 4 No
Neuropsychiatric Inventory- Carer
Distress (NPI-D)
30 (8.3%) 1998 USA 12 6 Yes
Geriatric Depression Scale 19 (5.3%) 1982 USA 30 2 No
Beck Depression Inventory (BDI) 17 (4.7%) 1961 USA 21 4 No
Neuropsychiatric Inventory
Questionnaire (NPI-Q)
12 (3.3%) 2000 USA 12 6 Yes
Brief Symptom Inventory 8 (2.2%) 1983 USA 53 5 No
Hamilton Depression Scale 8 (2.2%) 1960 UK 17 3-5 No
Pittsburgh Sleep Quality Index 8 (2.2%) 1989 USA 24 1-4 No
Hospital Anxiety and Depression
Scale
7 (1.9%) 1983 UK 14 4 No
State-Trait Anxiety Inventory 7 (1.9%) 1970 USA 20 4 No
Positive and Negative Affect Scale
(PANAS)
5 (1.4%) 1988 USA 20 5 No
Hopkins Symptoms Checklist 4 (1.1%) 1974 USA 58 4 No
Positive Aspects of Caregiving 4 (1.1%) 2004 USA 9 5 Yes
Quality of life Short Form-36 (SF-36) 32 (8.8%) 1988 USA 36 2-6 No
EuroQoL (EQ-5D) 18 (5.0%) 1990 Europe 5 3 No
World Health Organization Quality of
Life-Bref (WHOQOL-BREF)
8 (2.2%) 1996 Global 26 5 No
Health Utilities Index Mark2 4 (1.1%) 1990 Canada 8 5-6 No
Social support and
relationships
Social Support Questionnaire 7 (1.8%) 1983 USA 27 6 No
Stokes Social Support network List 4 (1.1%) 1983 USA N/A Matrix N/A No
Staff competency
and morale
Maslach Burnout Inventory 10 (2.6%) 1981 USA 22 3-7 No
Approaches to Dementia
questionnaire
4 (1.1%) 2000 UK 19 5 Yes
1 Information given for the 28 item version (GHQ-28).
2 Information given for the Health Utilities Index Mark III (HUI3).
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shows the change in composition of carer outcome mea-
sures used over the years.Burden measures
The 44 measures in this category consisted of burden,
stress and strain. Burden was the second most popular
category of measure used in dementia carer research.
The Zarit Burden Interview (ZBI) [13] was most popular,
appearing in 76 studies (21%). The ZBI is dementia spe-
cific, originally a 29-item instrument but also available
as a shorter 12-item version [14]. Domains of the ZBI
cover physical health, psychological well-being, finances,
social life, and relationship with the person with demen-
tia. The earliest paper retrieved which included the ZBI
was published in 1994; the ZBI is still used currently.
The Revised Memory and Behavior Problem Checklist
(RMBPC) [15] was the second most popular measure,
appearing in 44 studies (12%). It is also dementia specific
and contains 24 items adapted from the Memory and
Behavior Problem Checklist (MBPC) [16]. The MBPC
assesses the frequency and severity of problems exhib-
ited by a person with dementia and their carer’s reaction
to these problems. As with the ZBI, the RMBPC has also
been in use since 1994 and is still used today.Mastery
Forty-three measures encompassing the family carer’s
coping, self-efficacy and competence were extracted. As
can be seen in Table 2, mastery measures were infre-
quently used in earlier studies. Currently, mastery mea-
sures account for 17% of the outcome measures
included in dementia carer research. The Sense of Com-
petence Questionnaire (SCQ) [17] was most popular,
appearing in 12 studies (3%) since the year 2000. The
SCQ was developed to measure the ability of carers to
cope with looking after people with dementia living at
home. Three domains are covered: satisfaction with the
person receiving care, satisfaction with one’s own per-
formance as a carer and the impact of caring on the per-





1985-89 5 2 (12%) 1 (6%) 11 (6
1990-94 10 8 (42%) 1 (5%) 7 (3
1995-99 33 27 (36%) 12 (16%) 30 (4
2000-04 86 68 (32%) 31 (15%) 69 (3
2005-09 148 99 (26%) 60 (16%) 131 (
2010-12 79 50 (21%) 40 (17%) 67 (2Mood
Mood measures were included the most frequently, and
currently account for almost one third of dementia carer
measures included. Sixty-one mood measures covering
anxiety, depression, sleep and general mental well-being
were extracted. The Center for Epidemiologic Studies
Depression Scale (CES-D) [18] was the most frequently
used measure, appearing from 1989 onwards. CES-D
was followed in frequency by the General Health Ques-
tionnaire (GHQ) [19] and the Neuropsychiatric
Inventory-Distress (NPI-D) [20]. The NPI-D primarily
assesses the frequency and severity of behavioural distur-
bances occurring in people with dementia, but also asks
carers to rate their reaction to the behaviours. The NPI-
D is one of the more recently developed mood mea-
sures, first appearing in the year 2000.The next most
popular measures were the Geriatric Depression Scale
[21] which was developed for use in an elderly popula-
tion, the Beck Depression Inventory (BDI) [22] and the
Neuropsychiatric-Questionnaire (NPI-Q) [23], a version
of the NPI-D suitable for use in a clinical setting which
has appeared in publications from 2006 onwards.
Quality of life measures
Thirty-two QoL measures were identified. While QoL
measure inclusion has increased over the years, only 16% of
included outcome measures are currently for QoL. Four
outcome measures were used most frequently: the Short
Form-36 (SF-36) [24], the EuroQoL (EQ-5D) [25]; the
World Health Organization Quality of Life-brief (WHO-
QOL-BREF) [26] and the Health Utilities Index (HUI) [27].
The SF-36 and EQ-5D appeared in publication from 2001
onwards, while the WHOQOL-BREF is a more recent,
appearing 2007 onwards.
The SF-36 evolved from the RAND Health Insurance
Experiment, a 15 year study of American health policy;
and the Medical Outcome Study of patients with chronic
illnesses [24]. The SF-6D was subsequently developed;
enabling preference based utility scores and QALYs to
be calculated from the SF-36 or SF-12 [28,29]. While it
is possible to use the SF-6D directly in a study, develo-
pers recommend using the SF-36 or SF-12 and thenes used, percentage composition for the time period




5%) 3 (18%) 0 0
7%) 1 (5%) 0 2 (11%)
0%) 1 (1%) 4 (5%) 1 (1%)
3%) 23 (11%) 16 (8%) 4 (2%)
34%) 44(11%) 33 (9%) 19 (5%)
9%) 38 (16%) 24 (10%) 14 (6%)
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the SF-6D are physical functioning, role limitation, social
functioning, pain, mental health and vitality.
The EQ-5D was developed in Europe and consists of a
questionnaire (EQ-5D) and a visual analogue scale (EQ-
VAS). The EQ-5D comprises five domains: mobility; self
care; usual activities; pain and discomfort; and anxiety
and depression. A scoring algorithm converts responses
into an index score which can be used to calculate a
QALY. On the EQ-VAS, respondents are presented with
a thermometer with markings representing the worst
and best imaginable health state. Respondents are asked
to draw a line to mark the level they would describe
their health as being. While the scoring of the EQ-5D is
preference based, the EQ-VAS is not.
The WHOQOL-BREF is derived from the WHOQOL-
100, an instrument developed by a global research team
and intended to be applicable cross-culturally [26]. The
domains of the WHOQOL-BREF can be broadly cate-
gorised into physical health, psychological wellbeing, so-
cial relationships and the environment. Preference based
utility scores are not available for either the WHOQOL-
BREF or WHOQOL-100.
The Health Utilities Index has two main versions: the
HUI2 used with children, and the HUI3 used with
adults. The HUI3 has eight domains: vision, hearing,
speech, ambulation, dexterity, emotion, cognition and
pain [27].
Social support and relationships
The earliest published use of a social support or rela-
tionship measure was in 1999. Twenty-seven measures
were identified in this category. Only the Social Support
Questionnaire [30] and the Stokes Social Support Net-
work List [31] were used consistently, neither was
developed for dementia carers. The Social Support
Questionnaire assesses the respondent’s perceived num-
ber of social support contacts and their satisfaction with
the social support available. The Stokes Social Support
Network List asks respondents to list people they have
contact with on a regular basis and whether or not they
are relatives. The respondent’s social network size and
composition is then determined. The Stokes Social Sup-
port Network List is a recent measure, appearing in pub-
lications dated 2006–2010.
Staff competency and morale
Staff competency and morale measures were included
from 1994 onwards. Twenty-one measures were identi-
fied. Only two questionnaires were used in four or more
studies; the Maslach Burnout Inventory [32] and the
Approaches to Dementia Questionnaire [33]. Burnout is
described as the emotional exhaustion and cynicism
experienced by staff involved with people-facing roles[32], and the consequences of burnout are low quality of
care, low morale and high staff turnover. The
Approaches to Dementia Questionnaire assesses the
carer’s attitude towards the care recipient.
Discussion
The key to selecting appropriate outcome measures is
defining what an intervention targets, and therefore
what a measure has to be able to capture. As can be
seen in Table 2, the composition of measures included
in dementia carer research has changed over time. In
earlier years, mood measures were the most prevalent.
While this is still true of current research, the gap be-
tween use of mood and burden measures has narrowed.
Measures capturing social support and relationships are
more commonly used now.
Whichever instrument is used, NICE prefers results
to be converted into a QALY to allow comparisons
across different illnesses and interventions [2]. In order
to satisfy QALY methodology, quality weights must be
based on preferences and anchored on an interval scale
which contains full health and death points [34].
Preference-based generic instruments, such as the EQ-
5D are preferred; however, ‘when EQ-5D utility data are
not available, direct valuations of descriptions of health
states based on standardised and validated HRQL mea-
sures included in the relevant clinical trial(s) may be
submitted. In these cases, the valuation of descriptions
should use the time trade-off method in a representative
sample of the UK population, with ‘full health’ as the
upper anchor, to retain methodological consistency with
the methods used to value the EQ-5D’ [2]. Validity of
the instrument selected is important for results to be
meaningful. The most popular measures in the QoL
category have been validated with members of the gen-
eral population.
The aggregation of carer and patient QALYs is rarely
undertaken; however, one trial of befriending for carers
of people with dementia presented the incremental cost-
effectiveness ratio (ICER), as calculated with the EQ-5D
for the QALY component, for both the carer alone and
the carer and person with dementia combined [35]. The
intervention was not cost-effective when the ICER was
calculated for the carer alone, but became cost-effective
when the spill-over effects on the person with dementia
were incorporated. Aggregation of QALYs needs to be
undertaken cautiously, with the information used to cal-
culate resulting ICERs explicitly stated to allow for com-
parisons with interventions where QALYs have not been
aggregated.
Out of the most popular instruments in the QoL cat-
egory, only weights for the EQ-5D were derived using
the time trade-off method. The SF-6D and HUI3 were
valued using a visual analogue scale and standard
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based scoring. Three possible explanations for differ-
ences in health state valuations between measures have
been put forward: coverage of descriptive systems, sensi-
tivity of dimensions and valuation methods [36]. Instru-
ments which describe more health states will pick up
smaller changes in health status and are more appropri-
ate for research where smaller health gains are expected
to be made [37], such as research involving carers. The
HUI3 can describe 972,000 health states; the SF-6D ei-
ther 7,500 or 18,000 depending on the version, while the
EQ-5D only describes 243 health states. A ‘ceiling effect’,
where higher health states are chosen more frequently,
is known to be a feature of the EQ-5D. In contrast, the
SF-6D appears to have a ‘floor effect’, with responses
clustered at the lower end of the scale. The floor effect
is amplified in population groups with more physical
health problems, so may not be an issue when conduct-
ing research with carers of people with dementia. This is
because although many carers do have health issues, one
may assume that they already have reasonable physical
health to be able to cope with the physical aspects of
caring.
The World Health Organisation defines health as ‘a
state of complete physical, mental and social well-being
and not merely the absence of disease or infirmity’; a def-
inition unchanged since 1948 [38]. Furthermore, the
seven determinants of health are suggested as: income
and social status, education, physical environment, social
support networks, genetics, health services and gender
[39]. This reinforces the idea that we need to go beyond
physical health measurement, and consider other attri-
butes affecting QoL. This is particularly relevant for de-
mentia carers, as research is primarily aimed at relieving
burden rather than improving physical health.
While the EQ-5D covers physical domains well there
is only one question on mental well-being. Due to the
dominance of physical domains, it is not particularly
sensitive to changes in carers of people with dementia,
who might not see changes in their physical health over
time though their QoL is still affected. This issue was
raised by Al-Janabi et al. [11], who posed that measuring
health related outcomes for carers places a ‘patient’ iden-
tity on carers. In a cross-sectional study involving carers
of people with dementia completing the HUI2, Neu-
mann et al. [40] found that the stage of Alzheimer’s Dis-
ease was a negative predictor of patient utility (as
reported by carers completing the HUI2 as a proxy);
however, the utility that carers reported for themselves
was insensitive to the stage of the care recipients demen-
tia. For research involving carers of people with demen-
tia it may be necessary to include additional outcome
measures alongside a generic primary outcome measure
for cost-effectiveness analysis.It has been found that disease specific instruments are
better at detecting QoL changes than generic instru-
ments [41]. The main advantage of disease specific
instruments is that they are sensitive to changes asso-
ciated with the disease in question; therefore studies do
not need a large sample size. A disadvantage is that co-
morbidities may be overlooked; by focusing on QoL
changes associated with one particular illness, separate
health issues are ignored. As people with dementia and
their carers tend to be older, co-morbidities and side
effects are particularly relevant. Disease specific instru-
ments are typically focused on the person with the ill-
ness; therefore using a population group measure may
be more appropriate for carers. Population specific mea-
sures cover a broader range of domains than disease spe-
cific instruments, with the additional benefit of being
more sensitive than a generic instrument. This review
found that the most popular instruments in the burden
category were developed specifically to measure burden
in dementia carers, combining disease specific with
population specific domains.
This review found 29 studies which included details of
costs; however, most of these were only partial economic
evaluations which provided cost-outcome descriptions.
Where cost-effectiveness analyses had been performed
the unit of effect was typically time e.g. cost per add-
itional year that the person with dementia lived at home,
cost per reduction in hours spent on care tasks per day.
Cost-utility analysis was included in 3 studies [35,42,43];
the outcome measures used were the EQ-5D, HUI2 and
the Caregiver Quality of Life Instrument. All three mea-
sures are suitable for QALY calculations. The study that
included the cost-utility analysis using the HUI2 [42]
aggregated carer and patient QALYs, which as men-
tioned above is not consistent with traditional QALY
methodology. 9 of the studies listing costs were proto-
cols, 7 planned to conduct cost-utility analysis using the
EQ-5D and 2 planned to conduct cost-utility analysis
using the SF-12 or SF-36.
Overall, burden and mood measures were the most
frequently used. The earliest article retrieved from the
searches was published in 1987 and included 4 mood
measures and 1 QoL measure. Outcome measures in the
mood category covered a broad range of symptoms from
overall mental well-being, anxiety, depression and sleep
quality. A variety of social support measures were used;
the two most frequently used measures were not specific
to dementia carers. Social support measures have grown
in popularity but are still not as frequently used as bur-
den, mastery, mood or QoL measures. The least fre-
quently used category of measure was the staff
competency and morale category. A large number of un-
specified measures were found, mainly due to poor
reporting of study methods precluding the authors of
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increased use of guidelines such as CONSORT [44], has
improved the quality of reporting of trials in recent
years.
Future directions
The ICECAP index of capability has been developed to
measure attributes of QoL rather than influences on
QoL e.g. health [45]. The theory is that QoL does not
decrease due to poorer health, but instead decreases
through limitations in what one can do as a result of
poor health i.e. individuals value the activities that they
can undertake rather than health itself. In this sense,
instruments such as the EQ-5D are only a proxy meas-
ure for QoL rather than a direct measure [46]. Two ver-
sions of the ICECAP are available: the ICECAP-O,
suitable for ages 65+; and the ICECAP-A, suitable for
ages 18+. The domains of the ICECAP-O are: love and
friendship; thinking about the future; doing things that
make you feel valued; enjoyment and pleasure and inde-
pendence. These domains were developed to measure
capability in older members of the general population
[47] and have a certain degree of overlap with the cat-
egories of burden, mastery, mood, quality of life, and so-
cial support and relationships. The domains of the
ICECAP-A are similar: security; loved and friendship; in-
dependence; achievement and enjoyment and pleasure.
Currently, an algorithm to convert ICECAP scores into
a QALY is not yet available. One way around this is to
perform a mapping exercise of ICECAP scores onto EQ-
5D scores. To be valid this would require considerable
time and financial resources to construct the necessary
data set.
The capability framework has also led to the develop-
ment of the Adult Social Care Outcomes Toolkit
(ASCOT) [48], an instrument to measure social care-
related QoL. While the ASCOT does not specifically
measure carer well-being, it is a step towards acknow-
ledging the importance of the care environment that a
person is living in. Domains of the instrument include:
control over daily life; personal cleanliness and comfort;
food and drink; personal safety; social participation and
involvement; occupation; accommodation cleanliness
and comfort; and dignity. While the domains are similar
the ICECAP, the advantage that the ASCOT tool has is
that it is a preference-based measure with scoring
reflecting preferences of the general population [49].
Conclusion
Few studies currently incorporate economic evaluations
alongside clinical trials as routine practice. The choice of
instrument used to measure QoL has implications for
whether or not a treatment is considered cost-effective
and potentially funded. Health economists need tochoose instruments appropriate for the population and
expected outcomes. Researchers need to consider ease
of administration and clarity of instrument to ensure as
many participants as possible complete questionnaires.
For carers of people with dementia, available time is
already restricted so there is a need to avoid overburden-
ing participants with lengthy questionnaires. If an instru-
ment is not sensitive enough to detect changes in QoL
for carers of people with dementia, the effect of an inter-
vention which may appear to be beneficial to partici-
pants are underestimated. Use of capability based
instruments such as the ICECAP and ASCOT should
enable decision-makers to compare the value of health
and social services that may improve the QoL of an indi-
vidual without necessarily improving their health, to
interventions that impact on both health and QoL [47].
Additional files
Additional file 1: Appendix 1: Search strategy.
Additional file 2: Appendix 2: Full list of carer outcome measures
extracted.
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